genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2020
BioCryst Pharmaceuticals
News
BioCryst Pharmaceuticals – Galidesivir
Industry News
BioCryst Halves Staff After Setbacks
Industry News
Merger Terminated between Presidio and BioCryst
Infectious Diseases
BioCryst Halts Enrollment in Phase III Peramivir Trial
Drug Discovery
BioCryst Buys Presidio in $101M Merger
Industry News
BioCryst Closes $30M Financing Deal for Clinical Development of Gout Treatment
Drug Discovery
Japan Approves BioCryst/Shionogi Intravenous Flu Vaccine for Use in Infants and Children
News
Shionogi Pays $14M for BioCryst’s Influenza Program in Japan
News
BioCryst Recipient of $102.6M to Develop Peramivir for Influenza
Scroll Up
Scroll Up
